Risk Factors for Symptomatic Pericardial Effusions Posthematopoietic Stem Cell Transplant

Table 1

Characteristics of patients developing pericardial effusions.

Factors	N	%
Overall	15	100
Sex
Male	10	66.7
Female	5	33.3
Diagnosis
Malignancy	5	33.3
Hemoglobinopathy	6	40
Immunodeficiency	4	26.7
Conditioning regimen
Myeloablative	13	86.7
With cyclophosphamide	13	86.7
Reduced intensity	2	13.3
Hx CMV reactivation
Yes	7	46.7
No	8	53.5
Active infection within 2 weeks of PEF diagnosis
Yes	13	86.7
No	2	13.3
GVHD active at PEF dx
Yes	4	26.7
No	11	73.3
PEF diagnosis and time from BMT
Under day +100	12	80.0
Over day +100	3	20.0
Patients on immunosuppression at time of PEF diagnosis
Yes	14	93%
No	1	7%

CMV, cytomegalovirus; PEF, pericardial effusion; GVHD, graft versus host disease.